High materiality9/10
Tenax Therapeutics price target raised to $40 from $34 at Guggenheim
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises TENX target to $40; current price $12; large upside potential remains.
- Tenax Therapeutics
- price target raised
- Guggenheim
- target 40
- price 12
Key facts
- 01
Target: $40
- 02
Posted price: $12
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.